Does Favipiravir Reduce Mortality in Patients with COVID-19 ARDS and Severe Pneumonia?
Objective:Although there is no antiviral treatment specific to the virus, favipiravir has entered the treatment routine as an antiviral in our country in May 2020. In this study, in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) acute respiratory distress syndrome (ARDS)...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Yayinevi
2021-12-01
|
| Series: | Türk Yoğun Bakim Derneği Dergisi |
| Subjects: | |
| Online Access: |
http://www.turkishjic.org/archives/archive-detail/article-preview/does-favipiravir-reduce-mortality-in-patients-with/50667
|